Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Teligent Inc. TLGTQ

Healthcare Drug Manufacturers - Specialty & Generic
Teligent Inc is a specialty generic pharmaceutical company. Teligent develops, manufactures, and sells (under its own label) topical, injectable, complex, and ophthalmic pharmaceutical products in the U.S. and Canada. The product portfolio consists of hospital-based sterile injectable products and topical products (creams like Synalar and Spectazole; lotions like Kenalog; ointments like... see more

Recent & Breaking News (EXPM:TLGTQ)

MWA, ORN & TLGT - Bronstein, Gewirtz & Grossman, LLC Reminds of Class Action

Press Releases May 7, 2019

Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Teligent, Inc.

Business Wire May 6, 2019

Teligent, Inc. Announces First Quarter 2019 Results

GlobeNewswire May 6, 2019

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Teligent, Inc. To Contact The Firm

Press Releases May 3, 2019

Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Teligent, Inc.

Business Wire May 3, 2019

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teligent, Inc. - TLGT

GlobeNewswire May 2, 2019

Teligent, Inc. to Hold Conference Call for First Quarter 2019 Results on Monday May 6th, 2019

GlobeNewswire May 2, 2019

Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Teligent, Inc. Investors

Business Wire May 1, 2019

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Teligent, Inc. To Contact The Firm

Press Releases April 29, 2019

MWA, ORN & TLGT - Bronstein, Gewirtz & Grossman, LLC Reminds of Class Action

Press Releases April 29, 2019

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Teligent, Inc. Investors (TLGT)

Business Wire April 26, 2019

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Teligent, Inc. To Contact The Firm

GlobeNewswire April 25, 2019

Glancy Prongay & Murray LLP Announces Investigation on Behalf of Teligent, Inc. Investors

Business Wire April 25, 2019

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Teligent, Inc. Investors (TLGT)

Business Wire April 24, 2019

MWA, ORN & TLGT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action

Press Releases April 24, 2019

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teligent, Inc. - TLGT

PR Newswire April 23, 2019

MWA, ORN & TLGT - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action

Press Releases April 23, 2019

Robbins Arroyo LLP: Teligent, Inc. (TLGT) Misled Shareholders According to a Recently Filed Lawsuit

Business Wire April 22, 2019

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Teligent, Inc. To Contact The Firm

PR Newswire April 22, 2019

Teligent Provides Update on Orphan Drug Complete Response Letter

GlobeNewswire April 22, 2019